Ayala Pharmaceuticalsの簿価
Ayala Pharmaceuticalsの簿価 は何ですか。
Ayala Pharmaceuticals Inc.の簿価 は5.20です。
簿価 の定義は何ですか。
1株当たりの帳簿価額は、会社の資産から会社の負債を差し引いた数を発行済株式数で割ったものです。
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
NASDAQのセクタHealth Careにおける簿価 の企業と比べるAyala Pharmaceuticals
Ayala Pharmaceuticalsは何をしますか。
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Ayala Pharmaceuticalsと類似の簿価
- Duff & Phelps Select MLP and Midstream Fund Incの簿価 は5.20です。
- X-FAB Silicon Foundries SEの簿価 は5.20です。
- Estee Lauder Cosの簿価 は5.20です。
- China Zhongwangの簿価 は5.20です。
- Syncoraの簿価 は5.20です。
- Bank Of South Carolinaの簿価 は5.20です。
- Ayala Pharmaceuticalsの簿価 は5.20です。
- Canadian Net Real Estate Investment Trustの簿価 は5.21です。
- Corticeira Amorim SGPS SAの簿価 は5.21です。
- FAX Capitalの簿価 は5.21です。
- China Customer Relations Centers Incの簿価 は5.21です。
- Elateの簿価 は5.21です。
- Eldersの簿価 は5.22です。